Torrent Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹4,979 crore and net profit of ₹534 crore for the September 2026 quarter.
Torrent Pharmaceuticals (NSE: TORNTPHARM) closed at ₹4,689.50 on 20 Nov 2026, up 26.0% over the past year. Its market capitalisation is ₹1,78,374 crore and it trades at 82.2 times earnings.
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.